Alimera Historical Income Statement
| ALIM Stock | USD 3.00 0.11 3.54% |
Historical analysis of Alimera Sciences income statement accounts such as Interest Expense of 10.7 M, Selling General Administrative of 11.1 M or Selling And Marketing Expenses of 17.2 M can show how well Alimera Sciences performed in making a profits. Evaluating Alimera Sciences income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Alimera Sciences's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining Alimera Sciences latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Alimera Sciences is a good buy for the upcoming year.
Alimera |
About Alimera Income Statement Analysis
Alimera Sciences Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Alimera Sciences shareholders. The income statement also shows Alimera investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Alimera Sciences Income Statement Chart
Add Fundamental
Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Alimera Sciences. It is also known as Alimera Sciences overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Most accounts from Alimera Sciences' income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Alimera Sciences current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Alimera Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. To learn how to invest in Alimera Stock, please use our How to Invest in Alimera Sciences guide.At this time, Alimera Sciences' Depreciation And Amortization is very stable compared to the past year. As of the 6th of June 2024, Interest Expense is likely to grow to about 10.7 M, while Selling And Marketing Expenses is likely to drop about 17.2 M.
| 2021 | 2022 | 2023 | 2024 (projected) | Interest Expense | 5.4M | 5.9M | 10.2M | 10.7M | Depreciation And Amortization | 2.6M | 2.7M | 8.7M | 9.2M |
Alimera Sciences income statement Correlations
Click cells to compare fundamentals
Alimera Sciences Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Alimera Sciences income statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Depreciation And Amortization | 2.6M | 2.7M | 2.6M | 2.7M | 8.7M | 9.2M | |
| Interest Expense | 4.9M | 5.4M | 5.4M | 5.9M | 10.2M | 10.7M | |
| Selling General Administrative | 14.0M | 11.7M | 12.8M | 12.9M | 18.5M | 11.1M | |
| Selling And Marketing Expenses | 25.0M | 20.4M | 23.1M | 26.0M | 27.9M | 17.2M | |
| Other Operating Expenses | 59.2M | 51.3M | 59.2M | 65.8M | 82.2M | 48.2M | |
| Operating Income | (5.3M) | (501K) | (201K) | (11.6M) | (1.5M) | (1.5M) | |
| Ebit | (5.3M) | (501K) | (201K) | (11.6M) | (1.5M) | (1.5M) | |
| Research Development | 11.0M | 9.7M | 13.8M | 16.2M | 16.6M | 10.7M | |
| Ebitda | (2.6M) | 2.2M | 2.4M | (8.9M) | 7.3M | 7.6M | |
| Total Operating Expenses | 52.6M | 44.4M | 52.2M | 57.8M | 62.6M | 44.3M | |
| Income Before Tax | (10.2M) | (5.4M) | (3.9M) | (18.1M) | (20.0M) | (21.0M) | |
| Total Other Income Expense Net | (5.0M) | (4.9M) | (3.7M) | (6.4M) | (18.6M) | (17.6M) | |
| Net Income | (10.4M) | (5.3M) | (4.4M) | (18.1M) | (20.1M) | (21.1M) | |
| Income Tax Expense | 216K | (68K) | 438K | 28K | 85K | 80.8K | |
| Total Revenue | 53.9M | 50.8M | 59.0M | 54.1M | 80.8M | 84.8M | |
| Gross Profit | 47.3M | 43.9M | 52.0M | 46.2M | 61.2M | 32.6M | |
| Net Income From Continuing Ops | (10.4M) | (5.3M) | (4.4M) | (18.1M) | (20.1M) | (21.1M) | |
| Cost Of Revenue | 6.6M | 6.9M | 7.0M | 8.0M | 19.6M | 20.6M | |
| Non Operating Income Net Other | 193K | (1.8M) | (84K) | 474K | 545.1K | 337.2K | |
| Net Income Applicable To Common Shares | 21.9M | (10.4M) | (5.3M) | (4.4M) | (5.0M) | (5.3M) | |
| Tax Provision | 216K | (68K) | 438K | 28K | 77K | 112.2K | |
| Net Interest Income | (4.9M) | (5.4M) | (5.4M) | (5.9M) | (7.1M) | (7.4M) | |
| Reconciled Depreciation | 2.6M | 2.7M | 2.6M | 2.7M | 6.4M | 3.5M |
Becoming a Better Investor with Macroaxis
Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Alimera Sciences using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.Build Optimal Portfolios
Align your risk with return expectations
Additional Information and Resources on Investing in Alimera Stock
When determining whether Alimera Sciences is a strong investment it is important to analyze Alimera Sciences' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Alimera Sciences' future performance. For an informed investment choice regarding Alimera Stock, refer to the following important reports:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Alimera Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. To learn how to invest in Alimera Stock, please use our How to Invest in Alimera Sciences guide.You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Alimera Sciences. If investors know Alimera will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Alimera Sciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.25) | Revenue Per Share 2.413 | Quarterly Revenue Growth 0.699 | Return On Assets (0.01) | Return On Equity (1.97) |
The market value of Alimera Sciences is measured differently than its book value, which is the value of Alimera that is recorded on the company's balance sheet. Investors also form their own opinion of Alimera Sciences' value that differs from its market value or its book value, called intrinsic value, which is Alimera Sciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Alimera Sciences' market value can be influenced by many factors that don't directly affect Alimera Sciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Alimera Sciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Alimera Sciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Alimera Sciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.